Ifp Advisors, Inc Adaptive Biotechnologies Corp Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$7.8 - $10.11 $249 - $323	32 New	32 $0
Q2 2022 Sep 06, 2022	BUY	$6.4 - $14.73 $908 - $2,091	142 New	142 $6,000
Q2 2022 Aug 12, 2022	SELL	$6.4 - $14.73 $908 - $2,091	-142 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$10.12 - $28.9 $1,437 - $4,103	142 New	142 $1,000
Q3 2021 Oct 06, 2021	SELL	$30.02 - $39.87 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$32.22 - $44.59 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$37.26 - $67.74 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$45.01 - $65.47 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$35.79 - $48.81 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$24.95 - $48.38 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$16.96 - $34.16 $0 - $0	0 New	0 $0

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.